Table 3.
Induction chemoradiotherapy for locally advanced thymoma.
| Author | Sample size | Stage | Pathology | Chemo regimen | RT dose | Response rate % (CR+PR) | No. of R0/No. of surgery (%) |
|---|---|---|---|---|---|---|---|
| Wright et al. (32) | 10 | III-IVa | thymic tumor* | EP | 40-45Gy | 40% | 8/10 (80%) |
| Korst et al. (33) | 21 | – | thymic tumor* | EP | 40-45Gy | 47.6% | 17/21 (77%) |
| Wang et al. (34) | 33 | III | thymic tumor* | TP | 40Gy | 78.8% | 85.7% |
*including thymoma and thymic carcinoma.
RT, radiotherapy; EP, cisplatin+etoposide; TP, docetaxol+cisplatin; CR, complete remission; PR, partial remission.